Diligent Pharma, Inc. Announces Completion of $8.27 Million Series A Financing Raised
PRINCETON, N.J.--(BUSINESS WIRE)--Diligent Pharma Inc, a private vendor qualification and risk management organization, offering a centralized technology platform for streamlining vendor qualification in clinical trial execution announced today, the closing of an $8.27 Million Series A financing round led by FCA Ven...
Source: pharmiweb.com